Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 1Sanofi
02 3Dr. Reddy's Laboratories
03 1Polfa Tarchomin
04 1NanoAlvand
05 2Supriya Lifescience
06 1Ever Pharma
07 1AFT Pharmaceuticals
08 1Accord Healthcare Pty. Ltd.
09 3Accord healthcare
10 1Accure Labs
11 1Alembic Pharmaceuticals Limited
12 1Amneal Pharmaceuticals
13 1Apotex Inc
14 12AstraZeneca
15 2Aurobindo Pharma Limited
16 1Avyxa
17 1CHEMO
18 1Chia Tai Tianqing Pharmaceutical Group
19 1Curatis
20 1Dr Reddy's Laboratories (Pty) Ltd
21 1FORMATIVE PHARMA INC.
22 1Fresenius Kabi USA
23 1GetWell Pharmaceutical
24 1Glenmark Pharmaceuticals
25 1HBT Labs
26 1Hangzhou Jiuyuan Gene Engineering
27 1Hansoh Pharma
28 1Intas Pharmaceuticals
29 1InterPharma
30 1JAMP PHARMA
31 1Juno Pharma SA (Pty) Ltd
32 1Sagent Pharmaceuticals
33 1Sakar Healthcare
34 5Sandoz B2B
35 1Swasthya Healthcare
36 3Teva Pharmaceutical Industries
37 1TherDose Pharma
38 2Viatris
39 2Xiromed
40 1Zydus Pharmaceuticals
01 1Fulvestrant 250Mg 5Ml 1 Units Parenteral Use
02 1Fulvestrant 250Mg 5Ml 2 Units Parenteral Use
03 3INJ
04 1INJECTION
05 2Inj L?s
06 5Inj Solution
07 8Injection
08 2Injection fluid, resolution
09 1Liquid Injection
10 1Oily Solution
11 5PFS
12 1Pre Filled Syringes
13 1Prefilled Syringe
14 6SOLUTION
15 2SOLUTION FOR INJECTION, PRE-FILLED SYRINGE
16 19SOLUTION;INTRAMUSCULAR
17 1Solution for Injection
18 1Solution for Injection in Pre-Filled Syringe
19 4Blank
01 3DISCN
02 1Dossier Availability: Q1 2027
03 8Generic
04 1Lead Market Dossiers- Approved in both US & EU
05 1Lead Market Dossiers- Filed
06 1Originator
07 6Prescription
08 16RX
09 28Blank
01 1Ambiful
02 1Eranfu 250
03 3FASLODEX
04 1FASTELEV
05 17FULVESTRANT
06 1FULVESTRANT ACCORD
07 1FULVESTRANT EVER PHARMA
08 1FULVESTRANT INJECTABLE
09 3FULVESTRANT INJECTION
10 1FULVESTRANT-AFT
11 1FULVETHER
12 8Faslodex
13 1Frexivo
14 1Fularent
15 1Fuldexa
16 1Fulvedex 250mg/5ml
17 1Fulvestrant Accord
18 1Fulvestrant Mylan
19 3Fulvestrant Sandoz
20 1Fulvestrant Xiromed
21 1Fulvestrant Zentiva
22 1Fulvestrant-Teva
23 1TEVA-FULVESTRANT INJECTION
24 1VESTRANT
25 12Blank
01 4Australia
02 1Austria
03 6Canada
04 1China
05 10India
06 1Iran
07 2Italy
08 2Norway
09 1Poland
10 8South Africa
11 1Spain
12 2Sweden
13 7Switzerland
14 19USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Fulvestrant Zentiva
Dosage Form : Inj Solution
Dosage Strength : 250mg/5ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : FULVESTRANT
Dosage Form : SOLUTION;INTRAMUSCULAR
Dosage Strength : 250MG/5ML (50MG/ML)
Packaging :
Approval Date : 2020-08-07
Application Number : 209246
Regulatory Info : RX
Registration Country : USA
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Regulatory Info : Dossier Availability: Q1 2027
Registration Country : Poland
Brand Name :
Dosage Form : Solution for Injection
Dosage Strength : 250MG/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Availability: Q1 2027
Registration Country : Poland
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Fularent
Dosage Form : Prefilled Syringe
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 250MG/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.
Regulatory Info :
Registration Country : Austria
Brand Name :
Dosage Form : Solution for Injection in Pre-Filled Syringe
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Austria
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 50MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Approved in both US & EU
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 250MG/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Approved in both US & EU
Registration Country : India
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 50MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : FULVESTRANT
Dosage Form : SOLUTION;INTRAMUSCULAR
Dosage Strength : 250MG/5ML (50MG/ML)
Packaging :
Approval Date : 2019-03-04
Application Number : 210044
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FASLODEX
Dosage Form : SOLUTION;INTRAMUSCULAR
Dosage Strength : 250MG/5ML (50MG/ML)
Packaging :
Approval Date : 2002-04-25
Application Number : 21344
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FASLODEX
Dosage Form : SOLUTION;INTRAMUSCULAR
Dosage Strength : 125MG/2.5ML (50MG/ML)
Packaging :
Approval Date : 2002-04-25
Application Number : 21344
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FULVESTRANT
Dosage Form : SOLUTION;INTRAMUSCULAR
Dosage Strength : 250MG/5ML (50MG/ML)
Packaging :
Approval Date : 2019-07-23
Application Number : 208811
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FULVESTRANT
Dosage Form : SOLUTION;INTRAMUSCULAR
Dosage Strength : 250MG/5ML (50MG/ML)
Packaging :
Approval Date : 2019-08-19
Application Number : 210063
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FULVESTRANT
Dosage Form : SOLUTION;INTRAMUSCULAR
Dosage Strength : 250MG/5ML (50MG/ML)
Packaging :
Approval Date : 2020-02-07
Application Number : 211422
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FULVESTRANT
Dosage Form : SOLUTION;INTRAMUSCULAR
Dosage Strength : 250MG/5ML (50MG/ML)
Packaging :
Approval Date : 2019-05-20
Application Number : 210326
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FULVESTRANT
Dosage Form : SOLUTION;INTRAMUSCULAR
Dosage Strength : 250MG/5ML (50MG/ML)
Packaging :
Approval Date : 2019-08-22
Application Number : 207754
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FULVESTRANT
Dosage Form : SOLUTION;INTRAMUSCULAR
Dosage Strength : 250MG/5ML (50MG/ML)
Packaging :
Approval Date : 2019-11-21
Application Number : 209714
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FULVESTRANT
Dosage Form : SOLUTION;INTRAMUSCULAR
Dosage Strength : 250MG/5ML (50MG/ML)
Packaging :
Approval Date : 2019-08-22
Application Number : 205871
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FULVESTRANT
Dosage Form : SOLUTION;INTRAMUSCULAR
Dosage Strength : 250MG/5ML (50MG/ML)
Packaging :
Approval Date : 2019-05-14
Application Number : 205935
Regulatory Info : RX
Registration Country : USA
